References:
Schaller E, Macfarlane AJ, Rupec RA, Gordon S, McKnight AJ, Pfeffer K. 2002. Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol Cell Biol. 22(22):8035-43.
Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods. 174(1-2):5-19.
Zwadlo G, Brocker EB, von Bassewitz DB, Feige U, Sorg C. 1985. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol. 134(3):1487-92.
Murayama, T., M. Yokode, et al. 1999. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation. 99(13):1740-6. (IHC frozen, PubMed)
Geutskens, S., T. Otonkoski, et al. 2005. Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro. J Leukoc Biol. 78(4): 845-52. (IHC frozen, PubMed)
Torzewski, M., P. Shaw, et al. 2004. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Aterioscler Thromb Vasc Biol. 24(12): 2307-12. (IHC paraffin, PubMed)
Mackler, A., L.M. Green, et al. 2000. Distribution and activation of uterine mononuclear phagocytes in peripartum endometrium and myometrium of the mouse. Biol Reprod. 62(5):1193-200. (IHC paraffin, PubMed)
